Characterizing expanded access and compassionate use programs for experimental drugs
Miller JE, Ross JS, Moch KI, Caplan AL. Characterizing expanded access and compassionate use programs for experimental drugs. BMC Research Notes 2017, 10: 350. PMID: 28754150, PMCID: PMC5534121, DOI: 10.1186/s13104-017-2687-5.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicCompassionate Use TrialsDrugs, InvestigationalHumansProgram Development